ABSTRACT
INTRODUCTION

55
The prevalence of overweight and obesity has increased dramatically worldwide (1). 56
Frequently associated health risks are insulin resistance, elevated blood pressure and 57 hypercholesterolemia, which may lead to type 2 diabetes and cardiovascular disease (2). The 58 most important determinant of these problems is not the increased body mass per se, but 59 rather the total amount of fat, its distribution in the body and metabolic factors that are related 60 to fat tissue mass (3). Fat tissue is an active endocrine organ releasing adipokines (leptin, 61 adiponectin, resistin) and inflammatory factors, e,g, interleukin (IL) -6 (4). These mediators 62 modify carbohydrate-and lipid metabolism and contribute to insulin resistance, 63 hyperlipidemia and inflammatory processes (5). It is well known that inflammatory markers 64 are associated with fat mass in overweight and obese subjects (6), but this relation between fat 65 mass and inflammatory markers in lean subjects is not well documented (7). 66
Several methods are used to measure the amount of fat in adults. One of the most 67 accurate methods is Dual-energy X-ray absorptiometry (DXA) (7), but measuring fat this way 68 is costly and not readily available in clinical practice. Bioelectrical impedance analysis (BIA) 69 is more available and widely used outside hospitals (8), and an objective, quick and non-70 invasive method for assessment of fat and fat free mass (9, 10). Validation studies of BIA 71 against DXA showed that BIA is an adequate tool for prediction of fat (%) in healthy 72 populations (11). The most common population-level measure is probably estimation of body 73 mass index (BMI) (12). Whether BMI is a good marker to define obesity and health status is 74 debated (13). Studies have shown that BMI fails to differentiate between elevated body fat 75 and increased lean mass, especially in subjects with a BMI < 30 kg/m 2 , a frequent cut-off for 76 obesity (12). Other anthropometric measures, such as waist circumference, hip circumference, 77 waist-to-hip ratio, waist-to-height ratio and triceps skinfold, are often used to determine fat 78 distribution (13, 14) . Like BMI all these measures are just proxies of fat mass, but may predict 79 adverse outcomes (14). The INTERHEART Study showed that increasing waist-to-hip ratio 80 was a predictor of myocardial infarction in subjects with BMI < 20 kg/m 2 , subjects with 81 recommended weight (BMI 20-25 kg/m 2 ), as well as in overweight and obese subjects (BMI 82 > 25 kg/m 2 ) (15). Thus in further studies of the role of adipokines and inflammation in the 83 development of metabolic disorders it will be of interest to investigate if fat mass estimated by 84 anthropometric measures can predict levels of inflammatory markers not only in overweight, 85 but also in lean subjects. Our primary study aim was therefore to determine if any of the 86 frequently used anthropometric measures of fat mass (BMI, waist circumference, waist-to-hip 87 ratio, waist-to-height ratio and triceps skinfold) were associated with BIA-measured fat mass. 88
Furthermore we wanted to investigate the relationship between the anthropometric measure 89 with the strongest correlation with BIA, and adipokines, inflammatory markers, markers of 90 insulin resistance and lipids among healthy subjects in different BMI categories. Glucose was elevated (P = 0.03) in overweight men relative to the lean ones, but this was not 196 found among the women (Table 1) . 197 No significant differences in the plasma concentration of total cholesterol were found 198 between the overweight and lean subjects, but the LDL-cholesterol and triglyceride levels 199 were higher (P<0.05) whereas the HDL-cholesterol level was lower (P<0.05) in the 200 overweight relative to the lean subjects (Table 1) . 201
202
Inflammatory markers and adipokines 203
The overweight subjects had higher (P<0.05) levels of CRP and IL-6 than their lean 204 counterparts. Overweight subjects also had elevated (P<0.05) levels of the leptin and resistin, 205 compared to the lean subjects, while the level of adiponectin was lower (P<0.05). Overweight 206 women had higher levels of CRP than overweight men (P = 0.05) ( Table 2 ). and women in 207 both groups had higher (P<0.05) levels of leptin and adiponectin than men (Table 2) . No 208 significant difference in plasma levels of IGF-1 was observed. 209
210
Body composition in overweight and lean subjects 211
All body composition measures were significantly elevated in overweight compared with lean 212 subjects. Both overweight and lean women had higher TSF (P<0.001), whole body fat (%) 213 (P<0.01) and fat mass (P<0.01) than their male counterparts (Table 3) . Males had higher 214 levels for all other measurements than females except for hip circumference, mid upper arm 215 circumference and trunk fat mass. 216
217
Prediction of fat mass 218
To quantify the relationship between anthropometric estimates of fat mass and body fat 219 measured with BIA we performed multiple linear regression analyses (Table 4) . Hip 220 circumference had the highest standardized coefficient and explained most of the variation in 221 whole body-and trunk fat mass (% and kg) in both overweight and lean subjects. Waist-to-hip 222 ratio demonstrated the second highest standardized coefficient for whole body fat mass 223 (% and kg) and trunk fat (%) in overweight subjects. In lean subjects, TSF had the second 224 highest standardized coefficient for all BIA measures of fat mass. In summary, the results 225 showed that measurements of hip circumference were highly associated with whole body-and 226 trunk fat mass expressed in kg and percentage, in both lean and overweight subjects. The 227 results also indicated that an increase in hip circumference with one cm in both overweight 228 and lean subjects corresponded to an increase in the trunk body fat mass with 229 360 g. 230
231
Relationship between insulin resistance markers, lipids and inflammatory markers, and 232
body fat 233
Because measurements of hip circumference were closely related to BIA-derived fat mass in 234 both lean and overweight subjects, tertiles of hip circumference and whole body fat (%) were 235 used to analyse the relation between fat mass and markers of insulin resistance, lipids and 236 inflammatory markers (Tables 5 and 6 ). We also divided BMI into tertiles and performed the 237 same analysis (Table 7) . 238
In overweight subjects, IL-6 was reduced across tertiles of hip circumference 239 (Table 5 ). Levels of adiponectin and leptin increased, while resistin decreased. There was also 240 an elevation of IGF-1 and CRP concentrations. Levels of HOMA (P<0.05) and C-peptide 241 (P<0.05) increased and an elevation of triglyserides was seen, while HDL cholesterol 242 remained stable (Table 5 ). The same trends were found regarding tertiles of BMI in the 243 overweight subjects, except for a significant decrease of resistin (P<0.05) and elevated C-244 peptide (P<0.01) levels (Table 7) . Across tertiles of whole body fat (%) ( Table 6) Regarding the relation to tertiles of hip circumference in lean subjects (Table 5), IL-6  249 and adiponectin were reduced, and leptin (P<0.01) and resistin values were increased. Levels 250 of IGF-1, CRP, HOMA, C-peptide and triglycerides were increased, while HDL cholesterol 251 was reduced. Similar trends were found for tertiles of BMI in the lean subjects, except for 252 resistin which was decreased across tertiles, and CRP (P<0.05), which was significantly 253 increased (Table 7) . Like for the tertiles of hip circumference and BMI, leptin (P<0.01), IGF-254 1, CRP, HOMA and C-peptide, increased across tertiles of fat (%) ( Table 6 ). IL-6 values 255 however were stable and resistin (P<0.05) and triglycerides decreased, while HDL cholesterol 256 increased across tertiles of fat (%).  257   258  259  260  261  262  263  264  265  266  267  268  269  270  271  272  273  274  275  276  277  278  279  280   281   282   283   284   285   286   287   288   289   290 are possibly the most important determinants of these disorders (3). Hip circumference was 293 found to be the anthropometric measure that best reflected whole body fat (%) and trunk fat 294 (%) as measured with BIA, in both lean and overweight subjects. Interestingly we found a 295 tendency towards higher concentrations of leptin, CRP, and C-peptide, as well as adiponectin 296 and HDL, with higher fat (%), also in subjects with a BMI within the recommended range. 297
In this study we related frequently used anthropometric measures (BMI, TSF, waist 298 and hip circumference, waist-to-height, waist-to-hip ratio) to fat mass assessed by BIA. 299
Several studies have validated BIA by using DXA (15). In comparison with DXA, BIA tends 300 to overestimate fat mass (% and kg) in lean individuals and underestimate fat mass in obese 301 (17). Despite these limitations BIA is considered an acceptable tool for predicting body fat in 302 healthy populations (11). A recent study also demonstrated that BIA correlated significantly 303 with anthropometric measurements (18). This is in accordance with our study as we found 304 that TSF correlated significantly with BIA measures of fat (% and kg) in lean subjects and 305 waist circumference correlated with BIA-measures of fat in overweight subjects. Hip 306 circumference reflected BIA-measured fat in both groups. 307
In obesity the fat tissue produces adipokines (19) and cytokines, which may result in 308 chronic inflammation (20). It has been shown that systemic inflammation is higher in obese 309 than in normal-weight persons (21). Leptin is preferentially secreted by subcutaneous adipose 310 tissue (22), and the concentration is dependent on adipocyte size (23) as well as energy 311 balance (21). In our study we found a strong association between hip circumference and 312 whole body fat (%), and leptin levels. The same association was also found with BMI. 313
Normally, leptin levels are higher in obese individuals as demonstrated here. Interestingly we 314 observed that leptin levels increased with increasing fat (%) also in the lean group. One could 315 due to weight gain, which is known to produce higher leptin levels. However, in both study 317 groups the blood levels were measured during fasting and all subjects reported stable weight 318 for at least two months prior to inclusion. Few studies have shown the same trend with leptin 319 levels in lean people, but a positive association between fat mass accumulation, oxidative 320 stress indices and leptin levels has been observed (7), suggesting that fat mass-induced 321 oxidative stress may cause a dysregulation of adipokines, also in lean subjects. 322
A positive relationship between BMI, waist circumference and CRP has been 323 documented (24). This is in accordance with our study as we found that CRP increased with 324 increasing BMI and interestingly, this positive relationship was significant in lean subjects. 325
We also found an association between hip circumference and whole body fat (%) and CRP, 326 although not significant. These results confirm the findings by Arner et al (25) of an 327 association between inflammation and fat mass in lean individuals. There is also evidence that 328 IL-6, a key determinant of CRP production in hepatocytes, is secreted in proportion to the 329 expansion of fat mass, particularly in the abdominal region (26). We did, however, not detect 330 stronger associations with CRP and trunk fat mass than with other fat measures. Other adipose 331 tissue depots in ectopic sites (liver, heart, skeletal muscle) may contribute to the production of 332 inflammatory mediators in the absence of obesity (27) . 333
Chronic inflammation promotes insulin resistance and cardiovascular disease (5). Our 334 results show an increase in HOMA and C-peptide as hip circumference and BMI increased, 335
and an elevation of these markers from the lowest to the highest tertile of whole body fat (%) 336 in both groups. Low level of HDL-cholesterol is an important risk factor for cardiovascular 337 disease (28). One would expect a reduction in HDL-cholesterol as fat mass expands. This was 338 found in our study with increasing hip circumference in lean individuals and with increasing 339 BMI in both groups. In the overweight however, we found stable levels of HDL-cholesterol as 340 highest tertile of whole body fat (%). Elevated HDL-cholesterol levels were followed by an 342 inverse reduction of triglyceride levels. Studies have described a subset of obese individuals, 343 termed metabolically healthy, which appear to be resistant to the development of metabolic 344 disturbances (29). They have high fat mass and high BMI and high HDL, but low 345 triglycerides and visceral fat and normal insulin sensitivity. In our study a subgroup of the 346 overweight people, namely those with BMI > 30 kg/m², but no elevated HOMA, triglyceride-347 or LDL levels, had the highest levels of whole body fat (%). It should be noted that all the 348 overweight women in our study were in the highest tertile of fat (%). This may also explain 349 our findings regarding adiponectin: In the overweight group we found elevated levels of 350 adiponectin in the highest tertiles of hip circumference, whole body fat (%) and BMI. Earlier 351 studies show a decrease (30) in adiponectin levels as fat mass accumulates and an elevation 352 with weight loss (27). 353
The major strength of our study is that we examined a broad range of anthropometric 354 measures. Our study has some limitations since we used indirect measurements as indicators 355 of total and central fatness. It is therefore difficult to determine exactly the relative 356 contributions of subcutaneous versus visceral fat. The number of subjects was relatively low 357 and the results should be confirmed in a larger population. The age and gender heterogeneity 358 is also a limitation, although the variable was adjusted for. 359
In conclusion, we have showed that measurements of hip circumference to assess total 360 body and trunk fat (%) may represent a valid substitute to BIA measurements in both lean and 361 overweight subjects. Thus this is a highly feasible method outside the hospital setting in order 362
to identify people at risk of increased inflammation and insulin resistance. 363
Our results may also suggest that fat (%) is associated with elevation of risk factors for 364 lifestyle related disorders among lean persons. Although the choice of fat measure may 365 impact on the magnitude of these associations, adherence to a healthy lifestyle is also 366 important for people within the recommended range of BMI. The relationship between 367 markers of inflammation, insulin resistance and lipids in lean as well as overweight subjects 368
should be studied further in order to understand the role of fat mass in healthy subjects with 369 different BMI. Such knowledge may be of considerable interest for early identification of 370 subjects at risk of type 2 diabetes and cardiovascular disease. 371 372 9.
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